125 related articles for article (PubMed ID: 9584266)
21. Metabolic aspects of peroxisomal beta-oxidation.
Osmundsen H; Bremer J; Pedersen JI
Biochim Biophys Acta; 1991 Sep; 1085(2):141-58. PubMed ID: 1892883
[TBL] [Abstract][Full Text] [Related]
22. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
Paton BC; Sharp PC; Crane DI; Poulos A
J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
[TBL] [Abstract][Full Text] [Related]
23. Biochemistry of peroxisomes in health and disease.
Singh I
Mol Cell Biochem; 1997 Feb; 167(1-2):1-29. PubMed ID: 9059978
[TBL] [Abstract][Full Text] [Related]
24. A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3.
Ferdinandusse S; Jimenez-Sanchez G; Koster J; Denis S; Van Roermund CW; Silva-Zolezzi I; Moser AB; Visser WF; Gulluoglu M; Durmaz O; Demirkol M; Waterham HR; Gökcay G; Wanders RJ; Valle D
Hum Mol Genet; 2015 Jan; 24(2):361-70. PubMed ID: 25168382
[TBL] [Abstract][Full Text] [Related]
25. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
[TBL] [Abstract][Full Text] [Related]
26. Sterol carrier protein X (SCPx) is a peroxisomal branched-chain beta-ketothiolase specifically reacting with 3-oxo-pristanoyl-CoA: a new, unique role for SCPx in branched-chain fatty acid metabolism in peroxisomes.
Wanders RJ; Denis S; Wouters F; Wirtz KW; Seedorf U
Biochem Biophys Res Commun; 1997 Jul; 236(3):565-9. PubMed ID: 9245689
[TBL] [Abstract][Full Text] [Related]
27. The role of peroxisomes in intermediary metabolism.
Chandoga J
Bratisl Lek Listy; 1995 Sep; 96(9):465-86. PubMed ID: 8556358
[TBL] [Abstract][Full Text] [Related]
28. Isolated defect of peroxisomal beta-oxidation in a 16-year-old patient.
Santer R; Claviez A; Oldigs HD; Schaub J; Schutgens RB; Wanders RJ
Eur J Pediatr; 1993 Apr; 152(4):339-42. PubMed ID: 8482286
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
Poulos A; Sharp P; Fellenberg AJ; Johnson DW
Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
Street JM; Singh H; Poulos A
Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
[TBL] [Abstract][Full Text] [Related]
31. [Peroxisomal beta-oxidation].
Mannaerts GP; Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
[TBL] [Abstract][Full Text] [Related]
32. Molecular cloning and expression of human carnitine octanoyltransferase: evidence for its role in the peroxisomal beta-oxidation of branched-chain fatty acids.
Ferdinandusse S; Mulders J; IJlst L; Denis S; Dacremont G; Waterham HR; Wanders RJ
Biochem Biophys Res Commun; 1999 Sep; 263(1):213-8. PubMed ID: 10486279
[TBL] [Abstract][Full Text] [Related]
33. Role of peroxisomal fatty acyl-CoA beta-oxidation in phospholipid biosynthesis.
Hayashi H; Takahata S
Arch Biochem Biophys; 1991 Feb; 284(2):326-31. PubMed ID: 1989516
[TBL] [Abstract][Full Text] [Related]
34. Accumulation and impaired in vivo metabolism of di- and trihydroxycholestanoic acid in two patients.
Wanders RJ; Casteels M; Mannaerts GP; van Roermund CW; Schutgens RB; Kozich V; Zeman J; Hyanek J
Clin Chim Acta; 1991 Oct; 202(3):123-32. PubMed ID: 1839974
[TBL] [Abstract][Full Text] [Related]
35. Pristanic acid does not accumulate in peroxisomal acyl-CoA oxidase deficiency: evidence for a distinct peroxisomal pristanyl-CoA oxidase.
ten Brink HJ; Poll-The BT; Saudubray JM; Wanders RJ; Jakobs C
J Inherit Metab Dis; 1991; 14(5):681-4. PubMed ID: 1779614
[TBL] [Abstract][Full Text] [Related]
36. Effect of gemfibrozil on lipid biosynthesis from acetyl-CoA derived from peroxisomal beta-oxidation.
Hashimoto F; Ishikawa T; Hamada S; Hayashi H
Biochem Pharmacol; 1995 May; 49(9):1213-21. PubMed ID: 7763302
[TBL] [Abstract][Full Text] [Related]
37. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
[TBL] [Abstract][Full Text] [Related]
38. The inborn errors of peroxisomal beta-oxidation: a review.
Wanders RJ; van Roermund CW; Schutgens RB; Barth PG; Heymans HS; van den Bosch H; Tager JM
J Inherit Metab Dis; 1990; 13(1):4-36. PubMed ID: 2109148
[TBL] [Abstract][Full Text] [Related]
39. Pristanic acid beta-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
Biochim Biophys Acta; 1998 Apr; 1391(3):351-6. PubMed ID: 9555092
[TBL] [Abstract][Full Text] [Related]
40. Liver disease with altered bile acid transport in Niemann-Pick C mice on a high-fat, 1% cholesterol diet.
Erickson RP; Bhattacharyya A; Hunter RJ; Heidenreich RA; Cherrington NJ
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G300-7. PubMed ID: 15790756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
